Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids
Sisi Cai(Huazhong University of Science and Technology), Min Zhang(Shanxi Medical University), Hong Xiang Wang(Huazhong University of Science and Technology), Xiang Li(Scripps Research Institute), Zhaodong Zhong(Huazhong University of Science and Technology), Li Wang(University of Science and Technology of China)
Cited by 6
Related Papers
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
|The Lancet Global Health|2014|5.2k
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|238
Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR‐185/TGF‐β1
|Journal of Cellular Physiology|2018|172